Clinical Trials Browser

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell

NCT07406542 2026-02-12

A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer

Phase 3 Not yet recruiting

400 enrolled

Breast

Breast Neoplasms, Recurrence

NCT07306832 2025-12-29

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1 Not yet recruiting

18 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT06987058 2025-09-24

ROVER-01

Phase 2 Not yet recruiting

10 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Myeloid, Acute

NCT06281847 2025-09-18

RESOLVE AML001

Phase 1/2 Not yet recruiting

143 enrolled

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT07107204 2025-09-17

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

Phase 1/2 Not yet recruiting

116 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT07137637 2025-08-22

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Phase 1 Not yet recruiting

60 enrolled

Other hematologic neoplasm

Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

NCT06908772 2025-04-03

Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients

Phase 2/3 Not yet recruiting

390 enrolled

Recurrence

NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Phase 2 Not yet recruiting

150 enrolled

Head & Neck

Nasopharyngeal Neoplasms, Recurrence

NCT06845241 2025-02-25

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Phase 1/2 Not yet recruiting

68 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT06825845 2025-02-13

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

Not yet recruiting

1,500 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT06719479 2024-12-05

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

Phase 2/3 Not yet recruiting

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT06525350 2024-07-29

A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung Cancer

Phase 2 Not yet recruiting

256 enrolled

Recurrence

NCT06500507 2024-07-15

A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Phase 1 Not yet recruiting

90 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT06412458 2024-05-14

IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma

Phase 1 Not yet recruiting

9 enrolled

Sarcoma

Recurrence, Osteosarcoma

NCT05582590 2024-01-16

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Phase 1 Not yet recruiting

36 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Recurrence

NCT06093698 2023-10-23

A-337

Phase 1 Not yet recruiting

94 enrolled

Recurrence

NCT05798819 2023-04-05

A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 3 Not yet recruiting

424 enrolled

Recurrence

NCT05715840 2023-02-08

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Phase 3 Not yet recruiting

368 enrolled

Recurrence

NCT05503888 2022-08-17

Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung Cancer

Phase 1/2 Not yet recruiting

160 enrolled

Recurrence